FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $341,845 | -34.8% | 71,679 | -22.1% | 0.00% | 0.0% |
| Q1 2023 | $524,520 | -22.2% | 92,021 | +37.7% | 0.00% | -50.0% |
| Q4 2022 | $674,244 | -48.3% | 66,823 | +14.8% | 0.00% | -50.0% |
| Q3 2022 | $1,304,000 | -5.2% | 58,185 | +4.8% | 0.00% | +33.3% |
| Q2 2022 | $1,376,000 | -31.1% | 55,526 | +7.9% | 0.00% | +50.0% |
| Q1 2022 | $1,996,000 | +59.9% | 51,482 | +141.4% | 0.00% | -33.3% |
| Q4 2021 | $1,248,000 | +19.4% | 21,330 | +20.9% | 0.00% | 0.0% |
| Q3 2021 | $1,045,000 | -14.9% | 17,642 | +24.7% | 0.00% | 0.0% |
| Q2 2021 | $1,228,000 | +22.8% | 14,144 | +16.6% | 0.00% | 0.0% |
| Q1 2021 | $1,000,000 | – | 12,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |